Comparison of Direct Oral Anticoagulants for Acute Hospital Mortality in Venous Thromboembolism

ConclusionOn PS-matched analysis, there was a difference in in-hospital mortality, especially in the rivaroxaban and apixaban group. Identifying the clinical characteristics of patients associated with each DOAC, as well as prognosis, will be useful in determining treatment strategies for VTE.
Source: American Journal of Cardiovascular Drugs - Category: Cardiology Source Type: research